Position in LIVN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$10,104,451
+$349,916 QoQ
Shares Held
158,975
+0.3% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in LIVN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,402,735,897 across 83 Medical Devices names. LIVN ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,876,810 | $295,362,082 | |
| 2 | SYK |
Stryker Corp
|
633,935 | $208,304,701 | |
| 3 | MDT |
Medtronic plc
|
2,241,292 | $194,207,951 | |
| 4 | BSX |
Boston Scientific Corp
|
2,674,641 | $167,833,722 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,067,753 | $85,505,660 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
763,138 | $54,320,162 | |
| 7 | DXCM |
Dexcom Inc
|
772,557 | $48,516,579 | |
| 8 | STE |
STERIS plc
|
214,808 | $47,500,493 |
All Filings in LIVN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,104,451 | 158,975 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,754,535 | 158,533 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,253,346 | 176,658 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,052,187 | 178,858 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,830,831 | 173,901 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $8,240,308 | 177,938 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $9,301,629 | 177,039 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,039,296 | 183,132 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $10,207,539 | 182,473 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,301,092 | 179,766 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $9,898,501 | 187,188 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,568,705 | 186,053 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,681,846 | 176,270 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,750,047 | 175,550 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,503,061 | 167,482 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $10,106,396 | 161,780 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,079,826 | 147,621 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $12,645,962 | 144,641 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $11,544,634 | 145,784 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,387,316 | 135,386 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $10,326,402 | 140,057 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $9,621,902 | 145,324 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,356,435 | 140,598 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,554,581 | 156,962 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,762,431 | 149,446 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||